GBA1 and Parkinson disease: The more rapid decline in motor and non-motor features in GBA1-PD patients should be considered in the context of personalized treatment strategies, e.g., individualized pharmacological treatment, physiotherapy or cognitive engagement strategies at the early course of the disease [89].